ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,753, issued on Aug. 18, was assigned to American Gene Technologies International Inc. (Rockville, Md.).
"HIV immunotherapy with no pre-immunization step" was invented by Haishan Li (Rockville, Md.), Tyler Lahusen (Rockville, Md.), Lingzhi Xiao (Rockville, Md.) and Charles David Pauza (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to immunotherapy for the treatment or prevention of HIV. In particular, the disclosure provides lentiviral vectors and associated methods that are optimized to treat HIV without a pre-immunization step."
The patent was filed on Jan. 9, 2018, under Application No. 16/4...